Director of Creatd, Inc. (NASDAQ:CRTD), Patterson Mark Richard, buys 2,200 shares worth $7,243
According to Creatd, Inc. s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 14 04:31 PM, company Director, Patterson Mark Richard disclosed buying 2,200 shares at a cost of $3.29. At the time of this transaction (Dec 11), this trade was worth $7,243 in total. As of Dec 11, Patterson Mark Richard now owns 157,932 shares in total worth about $596,982.96.
For the last few recent trades made by Creatd, Inc. (NASDAQ:CRTD) Director, Patterson Mark Richard, we have the following information:
SEC Form 4 filing: Dec 08: Bought 40,000 shares at the rate of $3.53 per share. Total worth of this trade was $141,281. Total number of shares owned as of Dec 08 were 155,732
COB and CEO of Facebook Inc (NASDAQ:FB), Zuckerberg Mark, sells 6,250 shares worth ,756,851
empowerednews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from empowerednews.net Daily Mail and Mail on Sunday newspapers.
COB and CEO of Facebook Inc (NASDAQ:FB), Zuckerberg Mark, sells 50,000 shares worth ,051,780
empowerednews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from empowerednews.net Daily Mail and Mail on Sunday newspapers.
Chief Medical Officer of Applied Therapeutics Inc. (NASDAQ:APLT), Perfetti Riccardo, sells 465 shares worth $9,514
According to Applied Therapeutics Inc. s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 09 09:55 PM, company Chief Medical Officer, Perfetti Riccardo disclosed selling 465 shares at a cost of $20.46. At the time of this transaction (Dec 09), this trade was worth $9,514 in total. As of Dec 09, Perfetti Riccardo now owns 0 shares in total worth about $0.0.
For the last few recent trades made by Applied Therapeutics Inc. (NASDAQ:APLT) Chief Medical Officer, Perfetti Riccardo, we have the following information:
SEC Form 4 filing: Nov 20: Sold 1,660 shares at the rate of $19.07 per share. Total worth of this trade was $31,662. Total number of shares owned as of Nov 20 were 0
Director of Replimune Group, Inc. (NASDAQ:REPL), Rhodes Jason P, sells 67,890 shares worth $3,120,459
According to Replimune Group, Inc. s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 09 07:54 PM, company Director, Rhodes Jason P disclosed selling 67,890 shares at a cost of $45.96. At the time of this transaction (Dec 07), this trade was worth $3,120,459 in total. As of Dec 07, Rhodes Jason P now owns 35,709 shares in total worth about $1,554,769.8599999999.
For the last few recent trades made by Replimune Group, Inc. (NASDAQ:REPL) Director, Rhodes Jason P, we have the following information:
SEC Form 4 filing: Dec 08: Sold 108,256 shares at the rate of $46.71 per share. Total worth of this trade was $5,056,591. Total number of shares owned as of Dec 08 were 32,234